Skip to main content

Table 1 High-intensity focused ultrasound (HIFU) ablation studies treating fibroadenomata

From: A review of ablative techniques in the treatment of breast fibroadenomata

Study

Number

Size (cm)

Age (years)

Device

Follow-up (months)

Therapeutic efficacy

Complications

Time (min)

Hynynen (2001)

9 (11)

1.9 ± 1.5 cm3 (0.7–6.5)a

29 (19–38)b

InSightec (transducer diameter 100 mm and radius curvature 80 mm)

6 (18–48)

Complete necrosis (n = 6), partial necrosis (n = 2), minor necrosis (n = 1) and no response (n = 2)

Oedema, tenderness

Tempany (2005)

102

InSightec (−)

Kovatcheva & Boulanger (2014)

42 (51)

3.9 ml (0.3–19.7)a

32 (16–52)a

EchoPulse (transducer diameter 60 mm, 3 MHz)

12

Reduction of 33.2 ± 19.1 % at 2 months, 59.2 ± 18.2 % at 6 months and 72.5 ± 16.7 % at 12 months

Skin burn (n = 3), hyperpigmentation (n = 1)

118 (60–255)a

Cavallo-Marincola (2014)

10

26 (18–34)a

JC HIFU (−)

50 % reduction after in maximum diameter after 3 months

Swelling, hardness of area

57.2 (40–100)a

Hahn (2016)

27

EchoPulse (transducer diameter 60 mm, 3 MHz)

12

Douek (2016)

50

EchoPulse (transducer diameter 60 mm, 3 MHz)

12

 

Brenin (2016)

20

EchoPulse (transducer diameter 60 mm, 3 MHz)

12

 

  1. aMean ± SD (range)
  2. bMedian (range)